1. Lin, Yuxiang, Zhang, Jie, Li, Yan, Song, Chuangui, Fu, Fangmeng. 2022. CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1. In Journal of translational medicine, 20, 17. doi:10.1186/s12967-021-03206-5. https://pubmed.ncbi.nlm.nih.gov/34991621/
2. Shigeta, Keisuke, Hasegawa, Masanori, Hishiki, Takako, Kosaka, Takeo, Oya, Mototsugu. 2023. IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer. In The EMBO journal, 42, e110620. doi:10.15252/embj.2022110620. https://pubmed.ncbi.nlm.nih.gov/36637036/
3. Wu, Fahong, Mao, Yudong, Ma, Tao, Wang, Jia, Zhang, Youcheng. 2022. CTPS1 inhibition suppresses proliferation and migration in colorectal cancer cells. In Cell cycle (Georgetown, Tex.), 21, 2563-2574. doi:10.1080/15384101.2022.2105084. https://pubmed.ncbi.nlm.nih.gov/35912542/
4. Liang, Jin Hua, Wang, Chong, Yiu, Stephanie Pei Tung, Guo, Rui, Gewurz, Benjamin E. 2021. Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival. In mBio, 12, e0153021. doi:10.1128/mBio.01530-21. https://pubmed.ncbi.nlm.nih.gov/34281398/
5. Huang, Hanying, Chen, Yanzhou, Li, Yang, Lin, Huanxin, Liang, Yang. 2024. Cytidine triphosphate synthase 1-mediated metabolic reprogramming promotes proliferation and drug resistance in multiple myeloma. In Heliyon, 10, e33001. doi:10.1016/j.heliyon.2024.e33001. https://pubmed.ncbi.nlm.nih.gov/39050461/
智鼠故事 
